More than 200 life sciences leaders, researchers, educators and economic development officials gathered at East Carolina University, putting Greenville at the center of a statewide conversation about ...

While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two ...

An index of St. Louis publicly traded stocks trailed the Nasdaq and S&P 500 during the third quarter. Here are the winners and losers.

Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being considered for ...

A foreign biotech firm plans to use the new University City site as a base for bringing its products and services to U.S. customers.

Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine developer is posting the ...

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) has issued an update. Asep Medical Holdings Inc. plans to raise up to $900,000 through a non-brokered private placement ...

The Cambridge, Massachusetts company is offering 9.72 million shares at $17 to $19 each and plans to list on Nasdaq under the ...

The latest installment in BioPharma Dive’s data visualization series features a look at the factors pressuring biotech stocks ...

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) has shared an update. Asep Medical Holdings Inc. plans to raise up to $900,000 through a non-brokered private placement ...

City Therapeutics, a Phase 1 biotech developing RNA interference therapies for thromboembolic diseases, announced terms for ...

Oct 9 (Reuters) - City Therapeutics on Friday said it is targeting a valuation of up to $956.3 million in its US initial public offering, as biotech companies press ahead with listings despite market ...